Hepatitis C virus infection in Italian patients with hypogammaglobulinemia

Clinical Therapeutics

Volumn 18, Issue SUPPL. B, 1996, Pages 96-107

  Quinti, Isabella ^a   Pandolfi, Franco ^b   Paganelli, Roberto ^a   Giovannetti, Antonello ^a   Sacco, Giovanna ^a   Oliva, Alessandra ^a   Aiuti, Fernando ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS C ANTIBODY; IMMUNOGLOBULIN; VIRUS RNA;

ADULT; ATAXIA TELANGIECTASIA; COMMON VARIABLE IMMUNODEFICIENCY; CONFERENCE PAPER; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMORAL IMMUNE DEFICIENCY; HYPERIMMUNOGLOBULINEMIA; HYPOGAMMAGLOBULINEMIA; IMMUNOGLOBULIN G DEFICIENCY; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; ITALY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; X LINKED AGAMMAGLOBULINEMIA;

EID: 0029912807     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(96)80201-3     Document Type: Conference Paper

References (27)

1. Lane R. Non-A non-B hepatitis from intravenous gamma-globulin. Lancet. 1983; 2:974-975.
2. Ochs H, Fisher S, Virant F. Non-A non-B hepatitis and intravenous gammaglobulin. Lancet. 1985;1:404-405.
3. Björkander J, Cunningham-Rundles C, Lundin P, et al. Intravenous immunoglobulin prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinemia or IgG subclass deficiency. Am J Med. 1988;84:107-111.
4. Yap PL, McOmish F, Webster ADB, et al. Hepatitis C virus transmission by intravenous immunoglobulin. J Hepatol. 1994; 21:455-460.
5. Centers for Disease Control. Outbreak of hepatitis C associated with intravenous immunoglobulin administration: United States, October 1993-June 1994. MMWR. 1994;43:505-509.
6. Björo K, Frøland SS, Yun Z, et al. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin. NEJM. 1994;331:1607-1611.
7. Docke WD, Simon HU, Fietze E, et al. Cytomegalovirus infection and common variable immunodeficiency. Lancet. 1991; 338:1597. Letter.
8. Smith CIE, Islam KB, Vorechovsky I, et al. X-linked agammaglobulinemia and other immunoglobulin deficiencies. Immunol Rev. 1994;138:159-184.
9. Taliani G, Guerra E, Rosso R, et al. Hepatitis C virus infection in hypogammaglobulinemic patients receiving long-term replacement therapy with intravenous immunoglobulin. Transfusion. 1995;35: 103-107.
10. Buck J, Purcell RH, Miller RH. Importance of primer selection for the detection of hepatitis C RNA with the polymerase chain reaction assay. Proc Natl Acad Sci USA. 1992;89:187-191.
11. Stuyver L, Rossau R, Wyseur A, et al. Typing of HCV isolates and characterisation of new subtypes using a line probe assay. J Gen Virol. 1993;74:1093-1102.
12. Quinti I, Paganelli R, Scala E, et al. Hepatitis C virus antibodies in gammaglobulins. Lancet. 1990;336:1377. Letter.
13. De Santis A, Paganelli R, Stefanoni R, et al. Prevalence of gallstones in patients with primary immunoglobulin deficiency: Evidence for lack of association. Dig Dis Sci. 1990;35:716-720.
14. Choi YS, Bigger WD, Good RA. Biosynthesis and secretion of hypogammaglobulinemia. Lancet. 1972;1:1149-1152.
15. Chiaramonte M, Stroffolini T, Caporaso N, et al. Hepatitis C virus infection in Italy: A multicentric seroepidemiological study. Ital J Gastroenterol. 1991;23: 555-558.
16. Quinti I, Pandolfi F, Paganelli R, et al. HCV infection in patients with primary defects of Ig production. Clin Exp Immunol. 1995;102:11-16.
17. Minor P, Pipkin P, Thorpe R, Thomas D. Antibody to hepatitis C virus in plasma pools. Lancet. 1990;2:188. Letter.
18. Lefrere JJ, Mariotti M, Trepo C, et al. Testing for HCV RNA in commercial intravenous immunoglobulins. Lancet. 1993; 341:834-835.
19. Quinti I, Pandolfi F, Sacco G, et al. Intravenous immunoglobulins may still infect patients. BMJ. 1994;308:856. Letter.
20. Greenberger PA, Walker CL, Fitzsimons TE, Roberts M. Hypogammaglobulinemia associated with cytomegalovirus pneumonia. J Infect Dis. 1991;193:631-633.
21. Tosato G, Magrath I, Koski I, et al. Activation of suppressor T cells during Epstein-Barr virus induced infectious mononucleosis. NEJM. 1979;301:1133-1137.
22. Oliva A, Quinti I, Scala E, et al. Immunodeficiency with hyperIgM in two female patients is not associated with abnormalities of CD40 or CD40 ligand expression. J Allergy Clin Immunol. 1995;96:1-8.
23. Soothill SF, Haves K, Dufgeon JA. The immunoglobulins in congenital rubella. Lancet. 1966;1:1385-1388.
24. Alter HJ, Purcell RH, Shih JW, et al. Detection of antibody of hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A non-B hepatitis. NEJM. 1989;321:1494-1500.
25. Esteban JI, Gonzales A, Hernandez JM, et al. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis. NEJM. 1990;332:1107-1112.
26. Francois M, Dubois F, Brand D, et al. Prevalence and significance of hepatitis C virus (HCV) viremia in HCV antibody-positive subjects from various populations. J Clin Microbiol. 1993;31:1189-1193.
27. Zeldis JB, Jensen P. Hepatitis C virus pathogenicity : The corner pieces of the jigsaw puzzle are found. Gastroenterology. 1994; 106:1119-1120.